The data supports the safety of this model which could theoretically provide a "plug and play" platform for testing therapies and vaccines using the original COVID-19 strain as well as variants of the virus, Open Orphan, which carried out the study, said in a statement.
Open Orphan is running the project, launched a year ago, with Imperial College London, the U.K. government's vaccines task force and the clinical company hVIVO.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: